Temp - HCP Contracting Specialist
- Employer
- Regeneron Pharmaceuticals, Inc.
- Location
- Sleepy Hollow, New York
- Start date
- Sep 20, 2021
View more
- Discipline
- Clinical, Clinical Medicine
- Required Education
- Bachelors Degree
- Position Type
- Full time
- Hotbed
- Pharm Country, Best Places to Work
Job Details
The HCP Engagement and Contracting temporary employee will provide a business critical function to the Teams responsible for Consultants and Speakers who provide services on behalf of Regeneron. Specifically, this individual will support the Due Diligence process for HCP Consultants. This person will be responsible to perform in-depth background checks of HCPs prior to contracting, then on a quarterly basis throughout the calendar year They will also be responsible for assisting the Senior Manager of HCP Contracting in processing payments to HCPs and creating HCP profiles within our contracting system.
• Conduct comprehensive background searches of Consultants and Speakers using
Regeneron’s resources, public databases and Thomson Reuters Risk ID tool.
• Process confidential personal information for Consultants and Speakers with the utmost
integrity and discretion.
• Assist HCP Contracting team and Speaker team with documentation of search results and
communicate/escalate findings to Legal and/or Compliance as appropriate.
• Stay abreast of all applicable Regeneron policies, procedures and government regulations
(federal, state and international) related to Due Diligence prior to contracting HCPs,
thereby supporting risk mitigation for Regeneron.
• Assist in ad hoc HCP Consultant assignments as related to the comprehensive HCP
contracting process, as needed.
• Prepare and submit payment request packets to Accounts Payable, while ensuring all
supporting documentation is included and compliant with Regeneron policies.
• Collect and consolidate required close-out documents for Consultants and Consultant
Engagements.
Company
Regeneron is a leading biotechnology company that invents life-transforming medicines for people with serious diseases. Founded and led for 30 years by physician-scientists, our unique ability to repeatedly and consistently translate science into medicine has led to seven FDA-approved treatments and numerous product candidates in development, all of which were homegrown in our laboratories. Our medicines and pipeline are designed to help patients with eye disease, allergic and inflammatory diseases, cancer, cardiovascular and metabolic diseases, infectious diseases, pain and rare diseases.
Regeneron is accelerating and improving the traditional drug development process through our proprietary VelociSuite® technologies, such as VelocImmune® which produces optimized fully-human antibodies, and ambitious research initiatives such as the Regeneron Genetics Center, which is conducting one of the largest genetics sequencing efforts in the world.
Stock Symbol: REGN
Stock Exchange: NASDAQ
- Website
- https://www.regeneron.com/
- Phone
- 914-847-7000
- Location
-
Corporate Headquarters
777 Old Saw Mill River Road
Tarrytown
New York
10591
United States
Get job alerts
Create a job alert and receive personalized job recommendations straight to your inbox.
Create alert